FHLS Translational Funding – CiC & TRAP

The newly launched FHLS Translational Funding 2021 call is open for applications to fund projects with a viable translational pathway towards practical application. It comprises two complementary schemes using match funding from external sources managed by UoL’s Faculty of Health & Life Sciences (FHLS).

It comprises the Medical Research Council (MRC) Confidence in Concept (CiC) in conjunction with the Wellcome Trust’s Institutional Translational Partnership Award (ITPA) Translational Research Access Programme (TRAP). Both schemes are open for applications from the start of January 2021 up to Tuesday 6th April with full details provided on the application form available on this page.

MRC: Confidence in Concept (CiC) 2021

The MRC CiC 2021 funding is to support the transition from discovery science to the early stages of therapeutic/diagnostic development relating to infectious disease. This aligns with University of Liverpool strategic priorities, encompasses a range of projects within the MRC Priority Challenge areas of antimicrobial resistance and prevention research, and aims to address the urgent need for improved antimicrobials, vaccines and novel therapies in healthcare.

The funding was secured by UoL’s FHLS from the Medical Research Council (MRC) to support a number of preliminary-stage translational projects. Supported projects should aim to provide sufficient preliminary data to establish the viability of an approach before seeking more substantive funding (e.g. from the Developmental Pathway Funding Scheme (DPFS)). Additional information on the MRC rationale for the original 2019 call for this funding is available on the MRC site.

Applications received for CiC by 6th April 2021 will be evaluated to determine the allocation of funds by the CiC Governance Board which includes external representation. Board membership and further details are provided on the application form available via this site. We expect to allocate up to £249,000 in this round of the CiC 2021, providing up to £50,000 per project.

Wellcome Trust Institutional Translational Partnership Award (ITPA): Translational Research Access Programme (TRAP)

The objective of TRAP is to provide pump priming funding with the explicit intention of promoting collaborative translational research within the University of Liverpool and its associated healthcare community, primarily to address health issues of the Liverpool City region.  It is intended to provide an opportunity for Team Science, led by pairs of researchers (a FHLS clinician/non-clinical investigator and a clinically active Consultant working in one of our eligible healthcare partner trusts OR a member of one of our two sister Faculties at the University of Liverpool) to mutually develop new areas of research that will progress towards applied outcomes or lead to applications for substantial external translational funding. 

 

TRAP is jointly funded by FHLS and the Wellcome Trust as part of the UoL-WT ITPA which runs Feb 2021-Jan 2023. Applications received for TRAP by 6th April 2021 will be evaluated to determine the allocation of funds by a panel of senior University of Liverpool academics along and with Liverpool Health Partners (LHP) representation. Further details are provided on the application form available via this site.  There will be four TRAP rounds over the next two years with £300k available per round.

 

Call opens

Call closes

4 Jan 2021

6 April 2021

7 June 2021

7 September 2021

1 November 2021

31 January 2022

1 May 2022

31 July 2022

 

All enquiries and applications for FHLS Translational Funding should be directed to: rob.ashworth@liverpool.ac.uk (CiC) or r.corbin@liverpool.ac.uk (TRAP)